Mesoblast (MESO) Receivables (2016 - 2025)

Mesoblast has disclosed Receivables across 10 years of filings, most recently posting $43.3 million for Q4 2025.

• Receivables for Q4 2025 came in at $43.3 million, up 1345.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $43.3 million (up 1345.26% YoY), and the FY2025 annual result was $14.9 million, down 29.05% from the prior year.
• Receivables came in at $43.3 million for Q4 2025 at Mesoblast, up from $14.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $43.3 million in Q4 2025 to a low of $2.9 million in Q1 2021.
• The 5-year median for Receivables is $5.6 million (2021), against an average of $9.3 million.
• Across the five-year window, Receivables slumped 31.35% in 2022 and soared 1345.26% in 2025, its largest moves.
• Mesoblast's Receivables stood at $6.0 million in 2021, then slipped by 15.43% to $5.1 million in 2022, then retreated by 21.84% to $4.0 million in 2023, then declined by 25.06% to $3.0 million in 2024, then jumped by 1345.26% to $43.3 million in 2025.
• The last three Receivables figures came in at $43.3 million (Q4 2025), $14.9 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.